MAC Clinical: Forging a pioneering life sciences at Citylabs

    18 October 2024 - Video, Manchester City Centre

    By Bruntwood SciTech

    As a clinical research organisation, proximity to healthcare infrastructure is transformative. By choosing to base their operations at Citylabs, MAC Clinical has embedded itself within a true scientific ecosystem. Positioned between the university and the Manchester Foundation Trust (MFT) hospitals, they benefit from an unprecedented collaboration that grants immediate access to vital clinical services, renowned academic experts, and an emergency NHS response team located just two minutes away.

    Our ecosystem has helped bridge the gap between private enterprise and public health to rapidly accelerate clinical trials, provide critical infrastructure, and drive the regional economy forward.

    Discover more about their drug development services at https://researchforyou.co.uk, or explore our interconnected community at Citylabs.

    I work in Research and Innovation, which supports research and innovation across the whole of MFT. We do around 1,400 studies at any one time and we usually recruit around 20,000 participants annually. MAC is a full-service contract research organisation that supports drug development in the pharmaceutical industry.

    The relationship between Bruntwood SciTech, MAC, and Manchester Foundation Trust is actually a true collaboration. They actually have access to our services; that includes lumbar puncture, also endoscopy services, and also access to the emergency response team. And we've timed it—they are here in two minutes and they deal with any emergency. It's the fact that Citylabs is here at the centre of both the university and the hospital sites that makes that possible.

    Through the collaborations that we have, we get introduced to a whole range of experts and equipment, and really, science that we would never get to see otherwise. And in return, I think we contribute enormously in that we can provide infrastructure for the clinical trials that are being run out of Manchester.

    We work in different ways by supporting each other; I think we can help grow the economy. We have a bit of a melting pot in Manchester. We have some great academic scientists, and we also have people like ourselves who are doing good clinical research. Individually, they are very good and they're very strong, but to bring them together means that we're able to get the best out of all the different parts.

    Share: